CSS
DOVA

Cubist Systematic Strategies’s Dova Pharmaceuticals, Inc. Common Stock DOVA Stock Holding History

Cubist Systematic Strategies’s Portfolio DOVA Stock Details DOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-9,190
Closed -$70K – 2514
2018
Q4 		$70K Buy
+9,190
New +$148K ﹤0.01% 1821

Other funds holding DOVA

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SMH
Sanders Morris Harris Houston, Texas $172M AUM 22.54% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Cubist Systematic Strategies's DOVA Position: Q1 2019 in Review

Cubist Systematic Strategies sold out of Dova Pharmaceuticals, Inc. Common Stock (DOVA) in Q1 2019, closing a stake of 9,190 shares — an estimated $70K sold.

Cubist Systematic Strategies first reported a position in DOVA in Q4 2018 and held it in 1 quarter. The position peaked at $70K in Q4 2018. 59 funds tracked by Wall St. Rank hold DOVA as of Q1 2019.

  • Cubist Systematic Strategies reported no remaining Dova Pharmaceuticals, Inc. Common Stock position as of Q1 2019 after selling out during the quarter.
  • Cubist Systematic Strategies sold 9,190 Dova Pharmaceuticals, Inc. Common Stock shares in Q1 2019, an estimated $70K.
  • Cubist Systematic Strategies first reported a position in Dova Pharmaceuticals, Inc. Common Stock in Q4 2018 and held it in 1 quarter.
  • Cubist Systematic Strategies's Dova Pharmaceuticals, Inc. Common Stock position peaked at $70K in Q4 2018.
  • 59 funds tracked by Wall St. Rank held Dova Pharmaceuticals, Inc. Common Stock as of Q1 2019.

Based on Cubist Systematic Strategies's 13F filing for Q1 2019, filed 15 May 2019.